T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virtual diabetes groups aim to lower blood sugar and blood pressure
Disease control OngoingThis study tests whether virtual group visits can help adults with type 2 diabetes and related heart conditions better manage their health. About 720 participants will join online group sessions led by healthcare providers. The main goal is to see if these visits lower blood suga…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New diabetes pill shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental tablet called ASC30 in 100 adults with type 2 diabetes. The goal is to see if it safely lowers blood sugar and body weight over 13 weeks compared to a placebo. Participants must have stable weight and a BMI of 23 or higher. This is a Phase 2 trial…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Bariatric surgery study aims to predict diabetes remission and spare patients painful liver biopsies
Knowledge-focused OngoingThis observational study follows 163 obese adults undergoing bariatric surgery in Bahrain. Researchers aim to create a non-invasive scoring system using blood markers and ultrasound to diagnose and monitor fatty liver disease (MASLD), potentially replacing the need for liver biop…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain • Aim: Knowledge-focused
Last updated May 26, 2026 08:59 UTC